Literature DB >> 23235487

Altered fibrin clot properties in patients with premature peripheral artery disease.

Agnieszka Okraska-Bylica1, Tadeusz Wilkosz, Lidia Słowik, Marta Bazanek, Małgorzata Konieczyńska, Anetta Undas.   

Abstract

INTRODUCTION: It has been shown that formation of denser and poorly lysable fibrin clots is observed in elderly patients with peripheral artery disease (PAD).
OBJECTIVES: The aim of the study was to test the hypothesis that premature PAD is associated with more prothrombotic fibrin clot phenotype. PATIENTS AND METHODS: Ex‑vivo plasma fibrin clot permeability, turbidity, and susceptibility to lysis were evaluated in 31 premature PAD patients (median ankle brachial index [ABI], 0.75; interquartile range, 0.5-0.8) aged 55 or less and 32 PAD patients (ABI, 0.66; 0.56-0.76) aged over 55 years. Subjects without PAD matched for age and sex (n = 40) served as controls.
RESULTS: Premature PAD patients were characterized by 32% lower clot permeability (Ks) (P <0.001), 7% longer clot lysis time (t50%) (P = 0.004), and 31% higher maximum D-dimer levels released from fibrin clots (D-Dmax) (P <0.001) compared with controls. These differences remained significant after adjustment for risk factors and medications. None of the fibrin clot parameters differed between premature and older PAD patients. There were correlations between fibrin clot parameters and CRP in premature PAD patients and with ABI in older PAD patients. In a multiple regression model, premature PAD and ABI were independent predictors of Ks, and premature PAD and plasma fibrinogen of the maximum absorbance of a fibrin gel.
CONCLUSIONS: Plasma fibrin clots show similarly abnormal prothrombotic phenotype in premature and older PAD patients. However, different factors influence fibrin clot parameters in these patient groups. Premature PAD was an independent predictor of clot permeability and maximum absorbance of a fibrin gel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23235487     DOI: 10.20452/pamw.1535

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  4 in total

1.  Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death.

Authors:  Florian Posch; Stefanie Hofer; Johannes Thaler; Lena Hell; Oliver Königsbrügge; Ella Grilz; Lisa-Marie Mauracher; Johanna Gebhart; Christine Marosi; Bernd Jilma; Ingrid Pabinger; Cihan Ay
Journal:  Transl Res       Date:  2019-08-29       Impact factor: 7.012

2.  Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.

Authors:  Piotr Szczepaniak; Michał Zabczyk; Anetta Undas
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

3.  Thrombin-generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause.

Authors:  Stefanie Hofer; Cihan Ay; Judit Rejtö; Alisa S Wolberg; Helmuth Haslacher; Silvia Koder; Ingrid Pabinger; Johanna Gebhart
Journal:  J Thromb Haemost       Date:  2019-07-15       Impact factor: 5.824

4.  Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long-term follow-up study.

Authors:  Agata Hanna Bryk; Małgorzata Konieczyńska; Maciej Polak; Dariusz Plicner; Maciej Bochenek; Anetta Undas
Journal:  Cardiovasc Diabetol       Date:  2021-02-18       Impact factor: 9.951

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.